Clinical Trials Directory

Trials / Unknown

UnknownNCT02014714

Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea

Randomized Comparison Study of Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Malaya · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Obstructive Sleep Apnea (OSA) is a common clinical problem with a reported prevalence of 2% to 4% in the general population. The incidence was double on patients who had a diagnosis of OSA going for orthopedics surgery. Little literature composed mostly of case reports or small retrospective case-control studies exist examining the use of intrathecal opioids on outcomes in OSA patients is inconclusive. The primary objective of this study is to compare the post operative respiratory effect after single dose intrathecal morphine and intrathecal fentanyl on orthopedics patients who suspected or undiagnosed obstructive sleep apnea. Hypotheses Undiagnosed OSA patients who received intrathecal morphine are more likely to have respiratory events post-operatively.

Detailed description

This is a prospective, randomized study to compare the post operative respiratory effect after single dose intrathecal morphine (0.1mg) and intrathecal fentanyl (40mcg) on orthopedics patients who suspected or undiagnosed obstructive sleep apnea.

Conditions

Interventions

TypeNameDescription
DRUGMorphineDrug: Morphine Depending on the randomization schedule, 0.1mg of morphine or will be added to the intrathecal mixture.
DRUGFentanylDrug: Fentanyl 40mcg Depending on the randomization schedule, 40μg of fentanyl will be added to the intrathecal mixture.

Timeline

Start date
2013-12-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2013-12-18
Last updated
2013-12-19

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT02014714. Inclusion in this directory is not an endorsement.